Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodes
- 31 December 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (2) , 150-153
- https://doi.org/10.1016/0959-8049(94)90076-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancerEuropean Journal Of Cancer, 1993
- High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.Journal of Clinical Oncology, 1993
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Hyperalimentation in autologous bone marrow transplantation for solid tumors. Comparison of total parenteralVersus partial parenteral plus enteral nutritionCancer, 1989
- GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATIONThe Lancet, 1989
- TRANSFUSION ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN AUTOLOGOUS BONE MARROW TRANSPLANTATIONThe Lancet, 1989
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow TransplantationNew England Journal of Medicine, 1988
- Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerBreast Cancer Research and Treatment, 1985
- Dose: A critical factor in cancer chemotherapyThe American Journal of Medicine, 1980
- Pathologic findings from the national surgical adjuvant breast project (protocol no. 4) vi. discriminants for five-year treatment failureCancer, 1980